Skip to main content
$62.82 -$0.12 (-0.2%)

04:00 PM EST on 03/05/21

NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 3 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Current Price $62.82 Mkt Cap $3.2B
Open $62.73 P/E Ratio 0.00
Prev. Close $62.82 Div. (Yield) $0.00 (0.0%)
Daily Range $61.13 - $63.71 Volume 667,104
52-Wk Range $28.55 - $67.70 Avg. Daily Vol. 820,052

Caps

How do you think NASDAQ:NUVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

218 Outperform
19 Underperform
 

All-Star Players

66 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Recent Community Commentary

Read the most recent pitches from players about NUVA.

Recs

0
Member Avatar mmmed (29.52) Submitted: 10/9/2020 1:21:20 PM : Underperform Start Price: $53.95 NASDAQ:NUVA Score: -5.76

the product will not sell well until elective surgeries return. covid is killing this co's performance.

Recs

0
Member Avatar Engineer123 (< 20) Submitted: 10/25/2018 4:33:06 AM : Outperform Start Price: $62.65 NASDAQ:NUVA Score: -43.21

Yes, ceo changes will improve company performance.com

Recs

0
Member Avatar wadethefred (82.64) Submitted: 6/10/2018 11:50:30 AM : Outperform Start Price: $53.00 NASDAQ:NUVA Score: -19.25

While top line growth is solid it is declining. However, international sales is booming. Yes, competition is heating up and margins are being squeezed, but future prospects are still bright and now at 35% off their high, I'm betting NuVasive outperforms the market. An aging baby boomer population should help the whole industry.

Leaderboard

Find the members with the highest scoring picks in NUVA.

Score Leader

TrackPoisedTo

TrackPoisedTo (< 20) Score: +297.15

The Score Leader is the player with the highest score across all their picks in NUVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 29.70 4/20/2009 Underperform NS $29.90 +110.10% +353.15% +243.05 0 Comment
schwah5 85.69 7/30/2008 Underperform NS $54.97 +14.28% +211.60% +197.32 0 Comment
woNroFeybdooG 26.95 11/2/2009 Underperform 5Y $36.60 +71.64% +268.41% +196.78 0 Comment
KWfool2 50.95 9/4/2008 Underperform 1Y $47.78 +31.48% +215.50% +184.02 0 Comment
Slbrown99 < 20 7/14/2010 Underperform 5Y $36.56 +71.83% +249.64% +177.82 0 Comment
cdbell1114 46.10 10/9/2012 Outperform 3Y $14.34 +338.08% +163.61% +174.47 0 Comment
DiggityDown 24.51 11/30/2009 Underperform 5Y $34.64 +81.35% +250.41% +169.06 0 Comment
ditex < 20 4/26/2010 Underperform 1Y $42.44 +48.02% +214.84% +166.82 0 Comment
marketbuyer < 20 11/22/2011 Outperform 5Y $12.99 +383.60% +221.86% +161.74 0 Comment
redfox18 99.92 10/4/2012 9/14/2017 Outperform 3Y $15.02 +318.24% +163.48% +154.76 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NUVA.